Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration.

Lopez-Moya M, Melgar-Lesmes P, Kolandaivelu K, de la Torre Hernández JM, Edelman ER, Balcells M.

Biomacromolecules. 2018 Apr 9;19(4):1234-1244. doi: 10.1021/acs.biomac.8b00077. Epub 2018 Mar 20.

2.

Quantification of thrombus formation in malapposed coronary stents deployed in vitro through imaging analysis.

Brown J, O'Brien CC, Lopes AC, Kolandaivelu K, Edelman ER.

J Biomech. 2018 Apr 11;71:296-301. doi: 10.1016/j.jbiomech.2018.01.044. Epub 2018 Feb 9.

PMID:
29452756
3.

Lost in translational filters between peers.

Kolandaivelu K, Tzafriri AR.

EuroIntervention. 2017 Dec 8;13(12):e1384-e1385. doi: 10.4244/EIJ-D-17-00904. No abstract available.

4.

Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Shashar M, Belghasem ME, Matsuura S, Walker J, Richards S, Alousi F, Rijal K, Kolachalama VB, Balcells M, Odagi M, Nagasawa K, Henderson JM, Gautam A, Rushmore R, Francis J, Kirchhofer D, Kolandaivelu K, Sherr DH, Edelman ER, Ravid K, Chitalia VC.

Sci Transl Med. 2017 Nov 22;9(417). pii: eaam8475. doi: 10.1126/scitranslmed.aam8475.

5.

The Systems Biocompatibility of Coronary Stenting.

Kolandaivelu K, Rikhtegar F.

Interv Cardiol Clin. 2016 Jul;5(3):295-306. doi: 10.1016/j.iccl.2016.02.001. Epub 2016 Jun 21. Review.

PMID:
28582028
6.

Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stents.

Kolandaivelu K, Bailey L, Buzzi S, Zucker A, Milleret V, Ziogas A, Ehrbar M, Khattab AA, Stanley JRL, Wong GK, Zani B, Markham PM, Tzafriri AR, Bhatt DL, Edelman ER.

EuroIntervention. 2017 Apr 20;12(17):2148-2156. doi: 10.4244/EIJ-D-15-00497.

7.

Microbial lysate upregulates host oxytocin.

Varian BJ, Poutahidis T, DiBenedictis BT, Levkovich T, Ibrahim Y, Didyk E, Shikhman L, Cheung HK, Hardas A, Ricciardi CE, Kolandaivelu K, Veenema AH, Alm EJ, Erdman SE.

Brain Behav Immun. 2017 Mar;61:36-49. doi: 10.1016/j.bbi.2016.11.002. Epub 2016 Nov 5.

8.

Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants.

O'Brien CC, Kolandaivelu K, Brown J, Lopes AC, Kunio M, Kolachalama VB, Edelman ER.

PLoS One. 2016 Feb 23;11(2):e0149178. doi: 10.1371/journal.pone.0149178. eCollection 2016.

9.

Vascular Response to Experimental Stent Malapposition and Under-Expansion.

O'Brien CC, Lopes AC, Kolandaivelu K, Kunio M, Brown J, Kolachalama VB, Conway C, Bailey L, Markham P, Costa M, Ware J, Edelman ER.

Ann Biomed Eng. 2016 Jul;44(7):2251-60. doi: 10.1007/s10439-015-1518-x. Epub 2016 Jan 5.

10.

Degree of bioresorbable vascular scaffold expansion modulates loss of essential function.

Ferdous J, Kolachalama VB, Kolandaivelu K, Shazly T.

Acta Biomater. 2015 Oct;26:195-204. doi: 10.1016/j.actbio.2015.08.009. Epub 2015 Aug 12.

11.

Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis.

Kleiman NS, Kolandaivelu K.

J Am Coll Cardiol. 2015 Jun 9;65(22):2416-9. doi: 10.1016/j.jacc.2015.03.576. No abstract available.

12.

The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.

Shivanna S, Kolandaivelu K, Shashar M, Belghasim M, Al-Rabadi L, Balcells M, Zhang A, Weinberg J, Francis J, Pollastri MP, Edelman ER, Sherr DH, Chitalia VC.

J Am Soc Nephrol. 2016 Jan;27(1):189-201. doi: 10.1681/ASN.2014121241. Epub 2015 May 27.

13.

A randomised trial of lung sealant versus medical therapy for advanced emphysema.

Come CE, Kramer MR, Dransfield MT, Abu-Hijleh M, Berkowitz D, Bezzi M, Bhatt SP, Boyd MB, Cases E, Chen AC, Cooper CB, Flandes J, Gildea T, Gotfried M, Hogarth DK, Kolandaivelu K, Leeds W, Liesching T, Marchetti N, Marquette C, Mularski RA, Pinto-Plata VM, Pritchett MA, Rafeq S, Rubio ER, Slebos DJ, Stratakos G, Sy A, Tsai LW, Wahidi M, Walsh J, Wells JM, Whitten PE, Yusen R, Zulueta JJ, Criner GJ, Washko GR.

Eur Respir J. 2015 Sep;46(3):651-62. doi: 10.1183/09031936.00205614. Epub 2015 Apr 2.

14.

Enhancing physiologic simulations using supervised learning on coarse mesh solutions.

Kolandaivelu K, O'Brien CC, Shazly T, Edelman ER, Kolachalama VB.

J R Soc Interface. 2015 Mar 6;12(104):20141073. doi: 10.1098/rsif.2014.1073.

15.

Non-adherence to cardiovascular medications.

Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt DL.

Eur Heart J. 2014 Dec 7;35(46):3267-76. doi: 10.1093/eurheartj/ehu364. Epub 2014 Sep 28.

PMID:
25265973
16.

Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations.

Martorell J, Santomá P, Kolandaivelu K, Kolachalama VB, Melgar-Lesmes P, Molins JJ, Garcia L, Edelman ER, Balcells M.

Cardiovasc Res. 2014 Jul 1;103(1):37-46. doi: 10.1093/cvr/cvu124. Epub 2014 May 19.

17.

Predicting response to endovascular therapies: dissecting the roles of local lesion complexity, systemic comorbidity, and clinical uncertainty.

Kolandaivelu K, Leiden BB, Edelman ER.

J Biomech. 2014 Mar 3;47(4):908-21. doi: 10.1016/j.jbiomech.2014.01.006. Epub 2014 Jan 13. Review.

PMID:
24495755
18.

Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER.

Circulation. 2013 Jan 22;127(3):365-76. doi: 10.1161/CIRCULATIONAHA.112.118174. Epub 2012 Dec 25.

19.

Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.

Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, Coleman L, Wong GK, Edelman ER.

Circulation. 2011 Apr 5;123(13):1400-9. doi: 10.1161/CIRCULATIONAHA.110.003210. Epub 2011 Mar 21.

20.

Antiplatelet therapy in coronary heart disease prevention.

Kolandaivelu K, Bhatt DL.

Cardiol Clin. 2011 Feb;29(1):71-85. doi: 10.1016/j.ccl.2010.10.001. Review.

PMID:
21257101
21.

Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence.

Kolandaivelu K, Bhatt DL.

Nat Rev Cardiol. 2010 Aug;7(8):461-7. doi: 10.1038/nrcardio.2010.71. Epub 2010 Jun 1. Review.

PMID:
20517286
22.

Echocardiographic capture of right ventricular wall rupture during inferior wall acute myocardial infarction.

Maron BA, Kolandaivelu K, Rhee DK, Bukhman AK, Edelman ER.

Am J Cardiol. 2009 May 15;103(10):1478-80. doi: 10.1016/j.amjcard.2009.01.357. Epub 2009 Apr 1.

PMID:
19427450
23.
24.

Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis.

Kolandaivelu K, Edelman ER.

J Biomech Eng. 2002 Dec;124(6):662-8.

PMID:
12596633
25.

A miniature mechanical ventilator for newborn mice.

Kolandaivelu K, Poon CS.

J Appl Physiol (1985). 1998 Feb;84(2):733-9.

Supplemental Content

Loading ...
Support Center